The sterile filtration market was USD 9,034.2 million in 2023, which will increase to USD 19,111.3 million, powering at an 11.0% compound annual growth rate, by 2030. This is because of the rising occurrence of chronic illnesses, increasing R&D activities among biotechnology and pharmaceutical firms, and growing government investment in drug development.
Usually, sterile filtration is employed to remove dangerous particles from a bulk solution. This is owing to the sterilization of heat, unwanted degradation of product can be initiated in biotech drug goods; therefore, a possible alternative is the sterile filtration of biopharmaceutical fluids. Thus, sterilizing membrane filtration is employed in order to inspect the possible biofilm formation and decrease the intensity of bioburden in process streams.
The cartridge filters category, based on product, led the industry, as this product provides greater productivity as well as cost-effectiveness. In addition, this product is ideal for uses where dust must be fully recovered or removed. Moreover, a cartridge filter contains tube filtration tools, which can be employed in nearly every industrial application to meet different demands.
The bioprocess category, based on application, will be the largest contributor to the sterile filtration market, during this decade. Filters, in bioprocesses, are usually employed to eliminate unnecessary particles like cell debris, from kill and samples viruses or various other microbes in the same culture.
The pharmaceutical & biopharmaceutical companies, based on end user, was the largest contributor to the industry, owing to the expansion in their research & development activities. Pharmaceutical firms spent around USD 140 billion on research and development in 2022 due to the surge in the requirement for drugs.
The food & beverage companies, on the other hand, is likely to advance at the fastest compound annual growth rate during this decade. This is because of the increasing count of innovative products produced by the major players, such as syringe filters and sterilization filters.
North America was the largest contributor to the industry in 2023, with more than 50% share. This can be mainly ascribed to the rising research & development activities of biotech & pharma firms for drug development, increasing healthcare expenses, and speedy technological improvements. All this is itself because of the continuous increase in the prevalence of chronic disorders.
APAC will advance at the fastest CAGR in the years to come because it is considered a promising hub for pharmaceutical firms. In addition, the surging population of China and India has resulted in a rise in the utilization of such technologies to clean drinking water.
With the surge in the incidence of chronic illnesses, the sterile filtration industry will continue to grow in the years to come.
SOURCE: P&S Intelligence